EMV Capital PLC (EMVC) RNS Announcements | Ticker

⌘K

EMV Capital PLC (EMVC) RNS Announcements | Ticker | Ticker

Date	Time	Date	TitleTitle (filtered)
24/02/26	12:38:28	24 Feb 2026	TR-1	TR-1
12/02/26	07:00:09	12 Feb 2026	Portfolio Update	Portfolio Update
02/02/26	07:00:07	2 Feb 2026	Trading and Portfolio Update	Trading and Portfolio Update
08/01/26	07:00:08	8 Jan 2026	PDMR Dealing	PDMR Dealing
23/12/25	07:00:07	23 Dec 2025	Sofant Technologies: Fundraising	Sofant Technologies: Fundraising
19/12/25	07:00:01	19 Dec 2025	Director/PDMR Dealing	Director/PDMR Dealing
10/12/25	07:00:09	10 Dec 2025	Wanda Health: Fundraising and Business Update	Wanda Health: Fundraising and Business Update
08/12/25	07:00:11	8 Dec 2025	Share Issue, PDMR Dealings & Total Voting Rights	Share Issue, PDMR Dealings & Total Voting Rights
04/12/25	07:00:01	4 Dec 2025	TR-1	TR-1
24/11/25	07:00:11	24 Nov 2025	Expansion of Senior Finance Leadership Team	Expansion of Senior Finance Leadership Team
20/11/25	07:00:15	20 Nov 2025	Portfolio Update	Portfolio Update
30/09/25	07:00:11	30 Sept 2025	Interim Results and Investor Presentation	Interim Results and Investor Presentation
22/09/25	07:00:12	22 Sept 2025	Asset Purchase Agreement with Destiny Pharma	Asset Purchase Agreement with Destiny Pharma
18/09/25	07:00:13	18 Sept 2025	Notice of Interim Results	Notice of Interim Results
30/06/25	12:22:30	30 Jun 2025	Result of AGM	Result of AGM
30/06/25	07:00:03	30 Jun 2025	Office move and Related Party Transaction	Office move and Related Party Transaction
27/06/25	07:00:08	27 Jun 2025	Q-Bot Limited Fundraising	Q-Bot Limited Fundraising
10/06/25	13:28:40	10 Jun 2025	TR-1	TR-1
06/06/25	15:12:12	6 Jun 2025	Notice of AGM and Annual Report & Accounts	Notice of AGM and Annual Report & Accounts
04/06/25	14:34:35	4 Jun 2025	Director/PDMR Shareholding	Director/PDMR Shareholding
04/06/25	07:00:10	4 Jun 2025	Preliminary results for the year ended 31 Dec 2024	Preliminary results for the year ended 31 Dec 2024
14/05/25	16:02:50	14 May 2025	PDS: Q1 Results and Clinical and Corporate Update	PDS: Q1 Results and Clinical and Corporate Update
09/05/25	10:30:58	9 May 2025	TR-1	TR-1
27/03/25	16:46:02	27 Mar 2025	PDS: Q4 Results and Clinical Programs Update	PDS: Q4 Results and Clinical Programs Update
07/03/25	16:26:27	7 Mar 2025	PDS: VERSATILE-003 Phase 3 Clinical Trial	PDS: VERSATILE-003 Phase 3 Clinical Trial
27/02/25	16:30:26	27 Feb 2025	PDS: up to $22mn Registered Direct Offering	PDS: up to $22mn Registered Direct Offering
05/02/25	15:24:50	5 Feb 2025	PDS Biotech reaffirms guidance for clinical trial	PDS Biotech reaffirms guidance for clinical trial
03/02/25	07:00:06	3 Feb 2025	ProAxsis: Status Update and Proposed Fundraise	ProAxsis: Status Update and Proposed Fundraise
06/01/25	16:42:57	6 Jan 2025	TR-1	TR-1
31/12/24	07:05:00	31 Dec 2024	Grant of Share Options	Grant of Share Options
31/12/24	07:00:05	31 Dec 2024	Q-Bot Fundraising	Q-Bot Fundraising
12/12/24	16:49:51	12 Dec 2024	TR-1	TR-1
09/12/24	07:00:06	9 Dec 2024	Wanda Health Fundraising	Wanda Health Fundraising
05/12/24	07:00:20	5 Dec 2024	Close of Fundraising and Result of Retail Offer	Close of Fundraising and Result of Retail Offer
03/12/24	13:24:09	3 Dec 2024	Result of Subscription	Result of Subscription
03/12/24	07:05:01	3 Dec 2024	WRAP Retail Offer	WRAP Retail Offer
03/12/24	07:00:07	3 Dec 2024	Proposed Subscription and Retail Offer; Update	Proposed Subscription and Retail Offer; Update
14/11/24	15:59:35	14 Nov 2024	Replacement RNS: PDS: Update, 3rd Quarter Results	Replacement RNS: PDS: Update, 3rd Quarter Results
14/11/24	15:23:11	14 Nov 2024	PDS: Clinical Programs Update, 3rd Quarter Results	PDS: Clinical Programs Update, 3rd Quarter Results
08/10/24	07:00:07	8 Oct 2024	Director/PDMR Shareholding	Director/PDMR Shareholding
03/10/24	07:00:06	3 Oct 2024	Director/PDMR Shareholding	Director/PDMR Shareholding
02/10/24	16:38:29	2 Oct 2024	PDS: 36-Month Overall Survival Rate announcement	PDS: 36-Month Overall Survival Rate announcement
30/09/24	07:00:09	30 Sept 2024	Interim Results	Interim Results
26/09/24	07:00:15	26 Sept 2024	Name change and AIM Rule 26 website	Name change and AIM Rule 26 website
16/09/24	14:31:43	16 Sept 2024	PDS: Updated Results, VERSATILE-002 Phase 2 Trial	PDS: Updated Results, VERSATILE-002 Phase 2 Trial
13/08/24	15:57:46	13 Aug 2024	PDS Biotech: Business Update and Q2 2024 Results	PDS Biotech: Business Update and Q2 2024 Results
02/08/24	12:21:26	2 Aug 2024	Replacement RNS: PDS Biotech Aligns with FDA	Replacement RNS: PDS Biotech Aligns with FDA
02/08/24	07:00:05	2 Aug 2024	PDS Biotech Aligns with FDA on Phase 3 Trial	PDS Biotech Aligns with FDA on Phase 3 Trial
30/07/24	07:00:10	30 Jul 2024	Q-Bot Fundraising	Q-Bot Fundraising
10/07/24	10:48:07	10 Jul 2024	Result of AGM	Result of AGM

Showing 1–50 of 173 announcements

Date	Time	Date	TitleTitle (filtered)
24/02/26	12:38:28	24 Feb 2026	TR-1	TR-1
12/02/26	07:00:09	12 Feb 2026	Portfolio Update	Portfolio Update
02/02/26	07:00:07	2 Feb 2026	Trading and Portfolio Update	Trading and Portfolio Update
08/01/26	07:00:08	8 Jan 2026	PDMR Dealing	PDMR Dealing
23/12/25	07:00:07	23 Dec 2025	Sofant Technologies: Fundraising	Sofant Technologies: Fundraising
19/12/25	07:00:01	19 Dec 2025	Director/PDMR Dealing	Director/PDMR Dealing
10/12/25	07:00:09	10 Dec 2025	Wanda Health: Fundraising and Business Update	Wanda Health: Fundraising and Business Update
08/12/25	07:00:11	8 Dec 2025	Share Issue, PDMR Dealings & Total Voting Rights	Share Issue, PDMR Dealings & Total Voting Rights
04/12/25	07:00:01	4 Dec 2025	TR-1	TR-1
24/11/25	07:00:11	24 Nov 2025	Expansion of Senior Finance Leadership Team	Expansion of Senior Finance Leadership Team
20/11/25	07:00:15	20 Nov 2025	Portfolio Update	Portfolio Update
30/09/25	07:00:11	30 Sept 2025	Interim Results and Investor Presentation	Interim Results and Investor Presentation
22/09/25	07:00:12	22 Sept 2025	Asset Purchase Agreement with Destiny Pharma	Asset Purchase Agreement with Destiny Pharma
18/09/25	07:00:13	18 Sept 2025	Notice of Interim Results	Notice of Interim Results
30/06/25	12:22:30	30 Jun 2025	Result of AGM	Result of AGM
30/06/25	07:00:03	30 Jun 2025	Office move and Related Party Transaction	Office move and Related Party Transaction
27/06/25	07:00:08	27 Jun 2025	Q-Bot Limited Fundraising	Q-Bot Limited Fundraising
10/06/25	13:28:40	10 Jun 2025	TR-1	TR-1
06/06/25	15:12:12	6 Jun 2025	Notice of AGM and Annual Report & Accounts	Notice of AGM and Annual Report & Accounts
04/06/25	14:34:35	4 Jun 2025	Director/PDMR Shareholding	Director/PDMR Shareholding
04/06/25	07:00:10	4 Jun 2025	Preliminary results for the year ended 31 Dec 2024	Preliminary results for the year ended 31 Dec 2024
14/05/25	16:02:50	14 May 2025	PDS: Q1 Results and Clinical and Corporate Update	PDS: Q1 Results and Clinical and Corporate Update
09/05/25	10:30:58	9 May 2025	TR-1	TR-1
27/03/25	16:46:02	27 Mar 2025	PDS: Q4 Results and Clinical Programs Update	PDS: Q4 Results and Clinical Programs Update
07/03/25	16:26:27	7 Mar 2025	PDS: VERSATILE-003 Phase 3 Clinical Trial	PDS: VERSATILE-003 Phase 3 Clinical Trial
27/02/25	16:30:26	27 Feb 2025	PDS: up to $22mn Registered Direct Offering	PDS: up to $22mn Registered Direct Offering
05/02/25	15:24:50	5 Feb 2025	PDS Biotech reaffirms guidance for clinical trial	PDS Biotech reaffirms guidance for clinical trial
03/02/25	07:00:06	3 Feb 2025	ProAxsis: Status Update and Proposed Fundraise	ProAxsis: Status Update and Proposed Fundraise
06/01/25	16:42:57	6 Jan 2025	TR-1	TR-1
31/12/24	07:05:00	31 Dec 2024	Grant of Share Options	Grant of Share Options
31/12/24	07:00:05	31 Dec 2024	Q-Bot Fundraising	Q-Bot Fundraising
12/12/24	16:49:51	12 Dec 2024	TR-1	TR-1
09/12/24	07:00:06	9 Dec 2024	Wanda Health Fundraising	Wanda Health Fundraising
05/12/24	07:00:20	5 Dec 2024	Close of Fundraising and Result of Retail Offer	Close of Fundraising and Result of Retail Offer
03/12/24	13:24:09	3 Dec 2024	Result of Subscription	Result of Subscription
03/12/24	07:05:01	3 Dec 2024	WRAP Retail Offer	WRAP Retail Offer
03/12/24	07:00:07	3 Dec 2024	Proposed Subscription and Retail Offer; Update	Proposed Subscription and Retail Offer; Update
14/11/24	15:59:35	14 Nov 2024	Replacement RNS: PDS: Update, 3rd Quarter Results	Replacement RNS: PDS: Update, 3rd Quarter Results
14/11/24	15:23:11	14 Nov 2024	PDS: Clinical Programs Update, 3rd Quarter Results	PDS: Clinical Programs Update, 3rd Quarter Results
08/10/24	07:00:07	8 Oct 2024	Director/PDMR Shareholding	Director/PDMR Shareholding
03/10/24	07:00:06	3 Oct 2024	Director/PDMR Shareholding	Director/PDMR Shareholding
02/10/24	16:38:29	2 Oct 2024	PDS: 36-Month Overall Survival Rate announcement	PDS: 36-Month Overall Survival Rate announcement
30/09/24	07:00:09	30 Sept 2024	Interim Results	Interim Results
26/09/24	07:00:15	26 Sept 2024	Name change and AIM Rule 26 website	Name change and AIM Rule 26 website
16/09/24	14:31:43	16 Sept 2024	PDS: Updated Results, VERSATILE-002 Phase 2 Trial	PDS: Updated Results, VERSATILE-002 Phase 2 Trial
13/08/24	15:57:46	13 Aug 2024	PDS Biotech: Business Update and Q2 2024 Results	PDS Biotech: Business Update and Q2 2024 Results
02/08/24	12:21:26	2 Aug 2024	Replacement RNS: PDS Biotech Aligns with FDA	Replacement RNS: PDS Biotech Aligns with FDA
02/08/24	07:00:05	2 Aug 2024	PDS Biotech Aligns with FDA on Phase 3 Trial	PDS Biotech Aligns with FDA on Phase 3 Trial
30/07/24	07:00:10	30 Jul 2024	Q-Bot Fundraising	Q-Bot Fundraising
10/07/24	10:48:07	10 Jul 2024	Result of AGM	Result of AGM

Showing 1–50 of 173 announcements

EMV Capital PLC RNS

EMV Capital PLC RNS